Total submissions: 11
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000250328 | SCV000312110 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000319976 | SCV000470721 | benign | Citrullinemia type II | 2018-01-12 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Illumina Laboratory Services, |
RCV000372383 | SCV000470722 | benign | Citrullinemia type I | 2016-06-14 | criteria provided, single submitter | clinical testing | |
ARUP Laboratories, |
RCV000250328 | SCV000884509 | benign | not specified | 2018-12-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001513948 | SCV001721658 | benign | Citrin deficiency | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001532820 | SCV001748558 | benign | Citrullinemia, type II, adult-onset | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001532821 | SCV001748559 | benign | Neonatal intrahepatic cholestasis due to citrin deficiency | 2021-07-01 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001354507 | SCV001870299 | benign | not provided | 2015-03-03 | criteria provided, single submitter | clinical testing | |
Breakthrough Genomics, |
RCV001354507 | SCV005265307 | benign | not provided | criteria provided, single submitter | not provided | ||
Natera, |
RCV001277072 | SCV001463807 | benign | Late-onset citrullinemia | 2020-09-16 | no assertion criteria provided | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001354507 | SCV001549143 | uncertain significance | not provided | no assertion criteria provided | clinical testing | Allele frequency is common in at least one population database (frequency: 57.961% in ExAC) based on the frequency threshold of 1.504% for this gene. Variant was observed in a homozygous state in population databases more than expected for disease. 4 reputable source/s reports the variant as benign, but the evidence is not available to the laboratory to perform an independent evaluation. A synonymous variant not located in a splice region. |